US Patent Issued to Bayer, The Broad Institute, Dana-Farber Cancer Institute on July 14 for "4H-pyrrolo[3,2-cpyridin-4-one compounds" (German, American Inventors)

पोस्टेड ऑन: 2026-07-14

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,836, issued on July 14, was assigned to Bayer AG (Leverkusen, Germany), The Broad Institute Inc. (Cambridge, Mass.) and Dana-Farber Cancer I... और पढ़ें

US Patent Issued to CISEN PHARMACEUTICAL on July 14 for "Aminopyrimidine compound as CDK2/4/6 triple inhibitor" (Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,837, issued on July 14, was assigned to CISEN PHARMACEUTICAL Co. LTD (Jining, China). "Aminopyrimidine compound as CDK2/4/6 triple inhibito... और पढ़ें

US Patent Issued to Shanghai Zheye Biotechnology on July 14 for "Aromatic compound and application thereof in antitumor drug" (Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,838, issued on July 14, was assigned to Shanghai Zheye Biotechnology Co. Ltd. (Shanghai). "Aromatic compound and application thereof in ant... और पढ़ें

US Patent Issued to Janssen Pharmaceutica on July 14 for "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors" (French, Belgian Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,839, issued on July 14, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibito... और पढ़ें

US Patent Issued to Hoffmann-La Roche on July 14 for "Process for the preparation of (9S)-N-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1octan-8-yl-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4triazolo[1,5-aazepin-2-amine and its solid form" (Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,840, issued on July 14, was assigned to Hoffmann-La Roche Inc. (Little Falls, N.J.). "Process for the preparation of (9S)-N-[3-(6-methylpyr... और पढ़ें

US Patent Issued on July 14 for "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" (British Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,841, issued on July 14. "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" was invented by Peter Hewitt (Craigavon, Great Britain), ... और पढ़ें

US Patent Issued to DANA-FARBER CANCER INSTITUTE on July 14 for "HCK as a therapeutic target in MYD88 mutated diseases" (American, Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,842, issued on July 14, was assigned to DANA-FARBER CANCER INSTITUTE INC. (Boston). "HCK as a therapeutic target in MYD88 mutated diseases"... और पढ़ें

US Patent Issued to BioCryst Pharmaceuticals on July 14 for "Pyrrolopyrimidine amines as complement inhibitors" (Alabama Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,843, issued on July 14, was assigned to BioCryst Pharmaceuticals Inc. (Durham, N.C.). "Pyrrolopyrimidine amines as complement inhibitors" w... और पढ़ें

US Patent Issued to BeOne Medicines I on July 14 for "Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibitors" (Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,844, issued on July 14, was assigned to BeOne Medicines I GmbH (Basel, Switzerland). "Imidazotriazine and pyrrolopyrimidine derivatives as ... और पढ़ें

US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on July 14 for "Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor" (Chinese Inventors)

पोस्टेड ऑन: 2026-07-14

Government News US Fed News Patentwipo

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,679,845, issued on July 14, was assigned to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY Co. LTD. (Shenzhen, China). "Crystal form of triazolopyridin... और पढ़ें

विशेष

Category

Source

Publication

Byline

Location

US Patent Issued to Bayer, The Broad Institute, Dana-Farber Cancer Institute on July 14 for "4H-pyrrolo[3,2-cpyridin-4-one compounds" (German, American Inventors)

US Patent Issued to CISEN PHARMACEUTICAL on July 14 for "Aminopyrimidine compound as CDK2/4/6 triple inhibitor" (Chinese Inventors)

US Patent Issued to Shanghai Zheye Biotechnology on July 14 for "Aromatic compound and application thereof in antitumor drug" (Chinese Inventors)

US Patent Issued to Janssen Pharmaceutica on July 14 for "Cyclin-dependent kinase 7 (CDK7) non-covalent inhibitors" (French, Belgian Inventors)

US Patent Issued to Hoffmann-La Roche on July 14 for "Process for the preparation of (9S)-N-[3-(6-methylpyrimidin-4-yl)-3-azabicyclo[3.2.1octan-8-yl-9-(2,3,4-trifluorophenyl)-6,7,8,9-tetrahydro-5H-[1,2,4triazolo[1,5-aazepin-2-amine and its solid form" (Chinese Inventors)

US Patent Issued on July 14 for "Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors" (British Inventors)

US Patent Issued to DANA-FARBER CANCER INSTITUTE on July 14 for "HCK as a therapeutic target in MYD88 mutated diseases" (American, Chinese Inventors)

US Patent Issued to BioCryst Pharmaceuticals on July 14 for "Pyrrolopyrimidine amines as complement inhibitors" (Alabama Inventors)

US Patent Issued to BeOne Medicines I on July 14 for "Imidazotriazine and pyrrolopyrimidine derivatives as KRAS G12C inhibitors" (Chinese Inventors)

US Patent Issued to SHENZHEN OPTIMUM BIOLOGICAL TECHNOLOGY on July 14 for "Crystal form of triazolopyridine-substituted indazole compound and preparation method therefor" (Chinese Inventors)